Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

News Conference News AHA 2023

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

Shelley Wood

November 14, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Caitlin E. Cox

August 31, 2022

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

News Conference News AHA 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Michael O'Riordan

November 13, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Conference News ESC 2019

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Michael O'Riordan

September 02, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

Advertisement

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

March 2024 Dispatch for the CV Team

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

New on the Scene Nonstatin Drugs: Experts Provide Guidance

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content